NAFLD in some common endocrine diseases: Prevalence, pathophysiology, and principles of diagnosis and management
youtu.be/AZPo454Fi2M?si via @YouTube Headed to DC to share what GLP-1s made possible and to fight for the people who still cant access them
5 Conclusion In conclusion, the role of metformin in attenuation of weight regain after semaglutide discontinuation needs to be explored in randomized controlled studies in different insulin resistant populations
As a weight loss doctor, I have witnessed firsthand the transformative effects that the right medication can have on a patients weight loss journey
Dimitris Papamargaritis has acted as a speaker for Novo Nordisk, Eli Lilly and Boehringer Ingelheim and Johnson and Johnson and has received grants from Novo Nordisk, Novo Nordisk UK Research Foundation, Academy of Medical Sciences/Diabetes UK, Health Education East Midlands and the NIHR
Glucagon-like Peptide-1 receptor agonists and suicidal ideation: analysis of real-word data collected in the european pharmacovigilance database